Search clinical trials for: Histologically confirmed neuroendocrine tumor

Total 16 results

Latin American Cooperative Oncology Group

Active, not recruiting

Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors (LACOG/GTG 0119)

Neuroendocrine Tumors | Carcinoma;Endocrine

Brazil, Peru
Nuclear Medicine Consultants, Inc.

Unknown

Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours

Neuroendocrine Tumor

United States
Wren Laboratories LLC

Enrolling by invitation

RegisterNET - A Registry for Neuroendocrine Tumors in the USA (RegisterNET)

Neuroendocrine Tumor | Neuroendocrine Carcinoma | Carcinoid

United States
Institut Claudius Regaud
AstraZeneca

Active, not recruiting

Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma (SIMILY)

Diffuse Large B-cell Lymphoma

France
Assistance Publique - Hôpitaux de Paris

Recruiting

METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors (PROMETHEP)

Hepatocarcinoma | Pancreatic Tumor

France
Hospices Civils de Lyon

Unknown

The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours (LyREMeNet)

Metastatic Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Health Care Costs

France
Huashan Hospital

Completed

MRS and 11C-methionine PET/CT in the Diagnosis of Glioma

Glioma

China
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects

Healthy

United States
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

Healthy

United States
Novartis Pharmaceuticals

Completed

Fingolimod -Response According to Coping - Evaluation (GRACE)

Multiple Sclerosis, Relapsing-Remitting

France
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia

Schizophrenia

United States
Medical University of Gdansk

Enrolling by invitation

Observation of Clozapine Treatment Safety in Bipolar Disorder. (CloGD)

Bipolar Disorder

Poland
Novartis

Completed

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Relapsing Multiple Sclerosis

Belgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
ViiV Healthcare

Completed

'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor

HIV Infections

Spain
Universidade Federal de Santa Catarina

Recruiting

Self-Reported Pain in Children Submitted to Single Infiltration of Articaine During Primary Molar Extraction

Anesthesia, Local | Dental Pain

Brazil
Radboud University Medical Center

Completed

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain (Delta-pain)

Abdominal Pain | Chronic Pancreatitis | Tetrahydrocannabinol | Cannabinoid

Netherlands

3

Subscribe